Partner Content Partner Content Preliminary Attendee List Released for Orphan Drugs & Rare D... Attendees Released for Orphan Drugs & Rare Diseases
Views & Analysis Listening to the Patient Voice: seek out the quietest voice ... The success or failure of patient centricity rests on getting the patient voice in the mix – not just listening to those who shout the loudest.
Events Partner Content Partnerships in Clinical Trials Europe | 27-29 November 2018... PCT: Let's Get Clinical
Views & Analysis How people power is building patient-centric pharma While everyone is agreed on the importance of patient-centric pharma, just one fifth of industry insiders said they knew “how” to achieve it.
Disease Spotlight Finding the roadmap for living with LHON Every patient faces their own journey through life, learning about their condition with the best tools available to them.
Partner Content Partner Content Carina Schey, University of Groningen, Orphan Drugs & Ra... Chair Invitation to Orphan Drugs & Rare Diseases 2018
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.